Product NDC: | 21695-422 |
Proprietary Name: | Ciprofloxacin |
Non Proprietary Name: | Ciprofloxacin |
Active Ingredient(s): | 10 mg/mL & nbsp; Ciprofloxacin |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 21695-422 |
Labeler Name: | Rebel Distributors Corp |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA077782 |
Marketing Category: | ANDA |
Start Marketing Date: | 20060828 |
Package NDC: | 21695-422-01 |
Package Description: | 20 mL in 1 VIAL (21695-422-01) |
NDC Code | 21695-422-01 |
Proprietary Name | Ciprofloxacin |
Package Description | 20 mL in 1 VIAL (21695-422-01) |
Product NDC | 21695-422 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Ciprofloxacin |
Dosage Form Name | INJECTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20060828 |
Marketing Category Name | ANDA |
Labeler Name | Rebel Distributors Corp |
Substance Name | CIPROFLOXACIN |
Strength Number | 10 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Quinolone Antimicrobial [EPC],Quinolones [Chemical/Ingredient] |